Answers are grounded in this paper and cite their sources.
Background Squamous cell carcinoma of the oral cavity is a very aggressive and poorly selectively treatable malignant tumour. The present study aimed to investigate the anticancer activity of sakuranetin (SKN)-functionalized zinc oxide nanoparticles (ZnO–SKN) in a human oral epidermoid carcinoma cell line (KB). Methods ZnO–SKN nanoparticles were synthesized and characterized by Fourier-transform infrared, XRD, and scanning electron microscope. Effects on cytotoxicity, intracellular reactive oxygen species (ROS), mitochondrial membrane potential, apoptosis, migration, colony formation, and apoptosis-related genes expression were evaluated by standard in vitro assays. Results Treatment with ZnO–SKN saw a reduction in viability of KB cells to 25% to 30% at 100 µg/mL, with at least 70% viable HOK cell population. It increased ROS levels, caused mitochondrial depolarization, and triggered apoptotic features, such as chromatin condensation and membrane blebbing. The colony formation was less than 20% inhibited, and the decrease in migration was 70% to 80%. The activation of the mitochondrial apoptotic pathway was confirmed by upregulation of CASP3 and BAX and downregulation of BCL2. Conclusion Overall, ZnO–SKN is a potential nanotherapeutic agent that can induce mitochondrial apoptosis by targeting ROS and not only inhibit the proliferation but also inhibit migration of oral cancer cells.
No takes yet. Share an insight, caveat, or question.
Ragavendran et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: